Mode
Text Size
Log in / Sign up
N/A Completed N=23 Screening

Evaluation of ApneaLink Plus Scoring Capabilities

Sleep Apnea, Central · Sleep Apnea, Obstructive
Source: ClinicalTrials.gov NCT00823134 ↗
Enrolled (actual)
23
Serious AEs
0.0%
Results posted
May 2020
Primary outcomePrimary: Assessment of the Apnoea-Hypopnea-Index (Number of Apneas (All Apneas, Obstructive, Mixed, Central) and Number of Hypopneas) Between ApneaLink Plus and a PSG System Within the Same Evaluation Period — 14.77; 12.14 events/hour — p=0.021

Summary

The purpose of this study is to investigate the following topics: * Determine the accuracy of ApneaLink Plus in separating Apneas into Obstructive Apneas, Mixed Apneas and Central Apneas. * Determine the accuracy of ApneaLink Plus in scoring Hypopneas according to the 2008 guidelines of the AASM = American Academy of Sleep Medcine. * Determine whether patients can start and stop the recorder and are able to attach the additional effort sensor by themselves using the patient instruction sheet

Outcome Measures

OutcomeResultp-value
PRIMARY
Assessment of the Apnoea-Hypopnea-Index (Number of Apneas (All Apneas, Obstructive, Mixed, Central) and Number of Hypopneas) Between ApneaLink Plus and a PSG System Within the Same Evaluation Period
14.77; 12.14 0.021 sig
PRIMARY
Correlation Coefficient of Apnoea-Hypopnea-Index (AHI) (PSG) - AHI (AL)
0.968
PRIMARY
Correlation Coefficient of Apnoea-Index (AI) (PSG) - AI (AL)
0.935
PRIMARY
Correlation Coefficient of Obstructive-Apnoea-Index (OAI) (PSG) - OAI (AL)
0.852
PRIMARY
Correlation Coefficient of Central-Apnoea-Index (CAI) (PSG) - CAI (AL)
0.939
PRIMARY
Correlation Coefficient of Apnoea-Index (HI) (PSG) - HI (AL)
0.754
PRIMARY
Correlation Coefficient of Obstructive-Apnoea-Index (ODI) (PSG) - ODI (AL)
0.905

Eligibility Criteria

Inclusion Criteria

  • Willing to give written informed consent
  • Adult patients who are 18 years of age or older
  • No alcohol consumption 12 hrs before and during the trial period
  • Normally sleep more than 3 hours per night

Exclusion Criteria

  • Unable to comprehend written and spoken German.
  • Pregnant
  • Patients who use of Bilevel PAP or CPAP therapy during the PSG
  • Unsuitable for inclusion in the opinion of the investigator
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00823134). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search